Physician profile

Maaz Iqbal

Interventional Pain Medicine · Mesa, AZ

NPI 1760778906

$10,273.42

in general payments reported to CMS, 2019-2025

22 companies · $848 in 2025

The $848 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).

See the full distribution for Interventional Pain Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,189.14
Travel and Lodging$337.96

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $5,820.38 2019-2025 Proclaim, Eterna
Nevro Corp. $1,189.71 2019-2024 Senza
Boston Scientific Corporation $777.24 2019-2024
Medtronic, INC. $651.64 2022-2025 Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv
Saluda Medical Americas, INC. $493.15 2024 Evoke
Spr Therapeutics, INC $414.89 2023 Sprint Pns System
Spinal Simplicity, LLC $193.56 2024-2025 Ha Minuteman G3-R
Sirtex Medical INC $144.60 2024 Sir-Spheres Microspheres
Painteq LLC $104.25 2023-2024 Painteq
Vertiflex, INC. $94.37 2019
Medtronic USA, INC. $75.86 2020
Globus Medical, INC. $55.98 2025 Senza
Fidia Pharma USA INC. $55.13 2022
Curonix LLC $46.39 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Ekos Corporation $33.10 2019
Show all 22 companies
CompanyGeneral paymentsYearsTop products
Electronic Waveform Lab, INC. $29.35 2024
Bioventus LLC $24.51 2024 Supartz Fx Sodium Hyaluronate
Amgen INC. $18.30 2019
International Rehabilitative Sciences, INC $14.78 2024 Rs 4i Plus Sequential Stimulator
Novartis Pharmaceuticals Corporation $12.78 2020
Zyla Life Sciences, INC. $11.88 2020
Pfizer INC. $11.57 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Maaz Iqbal

$10,273.42

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $848 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/171119/maaz-iqbal

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.